4//SEC Filing
Stevens Christopher James 4
Accession 0001140361-25-029144
CIK 0001281895other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:11 PM ET
Size
7.3 KB
Accession
0001140361-25-029144
Insider Transaction Report
Form 4
Stevens Christopher James
Chief Operating Officer
Transactions
- Award
Common Stock
2025-08-04+407,166→ 407,166 total - Award
Stock Option (Right to Buy)
2025-08-04+554,071→ 554,071 totalExercise: $3.07Exp: 2035-08-04→ Common Stock (554,071 underlying)
Footnotes (2)
- [F1]Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]This option represents a right to purchase a total of 554,071 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0002079768
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:11 PM ET
- Size
- 7.3 KB